Cargando…
Structural Bases for the Synergistic Inhibition of Human Thymidylate Synthase and Ovarian Cancer Cell Growth by Drug Combinations
SIMPLE SUMMARY: Drug combinations may help overcome drug resistance, a relevant cause of failure of ovarian cancer therapy. However, designing successful combinations requires a lengthy preclinical validation process. We have analyzed combinations of 5-fluorouracil and raltitrexed, two anticancer dr...
Autores principales: | Pozzi, Cecilia, Santucci, Matteo, Marverti, Gaetano, D’Arca, Domenico, Tagliazucchi, Lorenzo, Ferrari, Stefania, Gozzi, Gaia, Losi, Lorena, Tassone, Giusy, Mangani, Stefano, Ponterini, Glauco, Costi, Maria Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123127/ https://www.ncbi.nlm.nih.gov/pubmed/33923290 http://dx.doi.org/10.3390/cancers13092061 |
Ejemplares similares
-
Folic Acid–Peptide
Conjugates Combine Selective
Cancer Cell Internalization with Thymidylate Synthase Dimer Interface
Targeting
por: Marverti, Gaetano, et al.
Publicado: (2021) -
A Peptidic Thymidylate-Synthase Inhibitor Loaded on Pegylated Liposomes Enhances the Antitumour Effect of Chemotherapy Drugs in Human Ovarian Cancer Cells
por: Marverti, Gaetano, et al.
Publicado: (2020) -
Intracellular quantitative detection of human thymidylate synthase engagement with an unconventional inhibitor using tetracysteine-diarsenical-probe technology
por: Ponterini, Glauco, et al.
Publicado: (2016) -
Cyclic Peptides Acting as Allosteric Inhibitors of Human Thymidylate Synthase and Cancer Cell Growth
por: Pacifico, Salvatore, et al.
Publicado: (2019) -
The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines
por: Marverti, Gaetano, et al.
Publicado: (2019)